TAVR safe for small degenerating bioprosthetic aortic valves: study
Outcomes were surprisingly good for such a challenging group of patients, expert says
28th May 2019
Transcatheter aortic-valve replacement (TAVR) offers a safer solution for patients with failing surgical aortic bioprosthetic valves at high risk for reoperation, according to an observational post-market study.
Medtronic Evolut R valve. Photo: Medtronic
Surgical aortic valve replacement has often been the treatment of choice, but degeneration of the bioprosthetic
